Glial Cell Line-Derived Neurotrophic Factor Improves Survival of Dopaminergic Neurons in Transplants of Fetal Ventral Mesencephalic Tissue
- 31 October 1998
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 153 (2) , 195-202
- https://doi.org/10.1006/exnr.1998.6884
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral graftsNeuroReport, 1996
- GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned ratsCell and tissue research, 1996
- Altered Motor Function and Graft Survival Produced by Basic Fibroblast Growth Factor in Rats with 6-OHDA Lesions and Fetal Ventral Mesencephalic Grafts Are Associated with Glial ProliferationExperimental Neurology, 1996
- Fetal nigral transplantation as a therapy for Parkinson's diseaseTrends in Neurosciences, 1996
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- BDNF Enhances the Functional Reinnervation of the Striatum by Grafted Fetal Dopamine NeuronsExperimental Neurology, 1996
- Effects of Glial Cell Line-Derived Neurotrophic Factor on Developing and Mature Ventral Mesencephalic Grafts in OculoExperimental Neurology, 1995
- Expression of Neurotrophins by Midbrain Dopaminergic NeuronsExperimental Neurology, 1993
- Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphologyPeptides, 1986